Heterogenous response of B cell chronic lymphocytic leukaemia (B‐CLL) cells to anti‐human IgM antibody (anti‐μ) and B cell stimulatory factor 1 (BSF‐1)
- 1 January 1989
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 71 (1) , 47-51
- https://doi.org/10.1111/j.1365-2141.1989.tb06273.x
Abstract
Summary: B cell chronic lymphocytic leukaemia (B‐CLL) cells from seven patients were examined for 3H‐TdR uptake with anti‐human IgM antibody (anti‐μ) and B cell stimulatory factor 1 (BSF‐1)/IL‐4. B‐CLL cells from one patient could proliferate with anti‐μ plus BSF‐1, but not with BSF‐1 alone. B‐CLL cells from two patients responded to BSF‐1 alone; one could proliferate more by adding anti‐μ, but the proliferation of the other cells was inhibited by adding anti‐μ. On the other hand, B‐CLL cells from the other four patients responded neither to anti‐μ nor to anti‐μ plus BSF‐1. Surface densities of membrane IgM of B‐CLL cells were also analysed by fluorescence activated cell sorter (FACS), but there was no correlation between proliferative response (DNA synthesis) of B‐CLL cells to anti‐μ and densities of surface membrane IgM. These results show that there is a functional heterogeneity of B‐CLL cells with regard to proliferative response to anti‐μ and BSF‐1.This publication has 28 references indexed in Scilit:
- A major 50-kDa human B-cell growth factor-II induces both Tac antigen expression and proliferation by several types of lymphocytesCellular Immunology, 1988
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor IINature, 1986
- Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.The Journal of Experimental Medicine, 1986
- Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoterNature, 1986
- Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor.The Journal of Experimental Medicine, 1985
- T lymphocytes in B-cell chronic lymphocytic leukemia: Characterization by monoclonal antibodies and correlation with Fc receptorsClinical Immunology and Immunopathology, 1983
- Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.The Journal of Experimental Medicine, 1983
- Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes.The Journal of Experimental Medicine, 1978
- ISOLATION OF NORMAL T CELLS IN CHRONIC LYMPHATIC LEUKÆMIAThe Lancet, 1973